Wednesday, 19 December 2018
Latest news
Main » AbbVie Inc (ABBV) Position Lessened by Dupont Capital Management Corp

AbbVie Inc (ABBV) Position Lessened by Dupont Capital Management Corp

12 January 2018

About 2.20M shares traded. Crown Holdings, Inc. (CCK) has risen 7.50% since January 9, 2017 and is uptrending. It has underperformed by 21.16% the S&P500. Proficio Capital Partners LLC now owns 2,719 shares of the company's stock valued at $171,000 after buying an additional 43 shares during the last quarter. The institutional investor held 67,410 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $5.99 million, down from 112,325 at the end of the previous reported quarter. Deutsche Commercial Bank Ag stated it has 0.28% of its portfolio in AbbVie Inc. The stock decreased 0.73% or $0.03 during the last trading session, reaching $4.07. About 59,782 shares traded. It has underperformed by 6.07% the S&P500.

Investors sentiment decreased to 0.85 in 2017 Q3. The company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.02. 69 funds opened positions while 281 raised stakes. Schumacher Laura J sold $14.07 million worth of stock or 145,510 shares. Tortoise Inv Mgmt Limited Liability Corp owns 9,569 shares or 0.07% of their USA portfolio. (NASDAQ:LRCX) by 1,722 shares to 5,030 shares, valued at $930,000 in 2017Q3, according to the filing. Us Comml Bank De accumulated 2,137 shares. Moody Bancorporation Division stated it has 11,508 shares. Nomura Holdg holds 0.02% or 108,283 shares. Washington Trust stated it has 0.32% in AbbVie Inc. Moreover, Paragon Capital Mgmt has 0.35% invested in AbbVie Inc. (NYSE:ABBV). Kessler Investment Group Inc Limited Liability Corp has 1.35% invested in AbbVie Inc. (NASDAQ:CONE) for 1.45M shares. Trustco National Bank & Trust N Y, New York-based fund reported 31,609 shares. Diligent Invsts Ltd Liability Corp has invested 0.84% in Morgan Stanley (NYSE:MS). (NYSE:ABBV). Sector Pension Board holds 0.03% of its portfolio in AbbVie Inc. Therefore 41% are positive. Morgan Stanley had 89 analyst reports since July 21, 2015 according to SRatingsIntel. (NASDAQ:USCR) rating on Tuesday, August 8. Wells Fargo has "Hold" rating and $55.0 target. The company was upgraded on Tuesday, May 17 by Wells Fargo. Jefferies Group upped their price objective on AbbVie from $115.00 to $120.00 and gave the company a "buy" rating in a report on Thursday, January 4th. The rating was maintained by Leerink Swann with "Buy" on Tuesday, December 5. The stock of U.S. Concrete, Inc. The rating was maintained by Jefferies with "Buy" on Monday, June 26. (NYSE:AIG) earned "Underweight" rating by Atlantic Securities on Wednesday, November 4. The firm has "Buy" rating given on Thursday, April 21 by BB&T Capital. Capital Research Global Investors boosted its holdings in shares of AbbVie by 1.2% during the 2nd quarter. Following the completion of the sale, the executive vice president now directly owns 114,922 shares of the company's stock, valued at approximately $10,881,964.18.

Analysts await AbbVie Inc. (NYSE:CCK) to report earnings on February, 1. During the same quarter in the prior year, the company earned $1.21 earnings per share. ABBV's profit will be $2.28B for 17.68 P/E if the $1.43 EPS becomes a reality. After $1.57 actual EPS reported by Deere & Company for the previous quarter, Wall Street now forecasts -30.57% negative EPS growth. Oregon Public Employees Retirement Fund stated it has 0.37% of its portfolio in General Electric Company (NYSE:GE). The other 11 are split, though not evenly, between analysts who think you should buy its stock versus those who think you should sell it. The stock was sold at an average price of $90.55, for a total transaction of $1,657,065.00. About 199,736 shares traded.

Analyst Thoughts About AbbVie Inc. Therefore 57% are positive. LendingClub Corporation had 62 analyst reports since July 31, 2015 according to SRatingsIntel. Boston Rech Management has invested 2.4% in AbbVie Inc. That's a potential 1.27 gain from where (NYSE:ABBV) has been trading recently. More interesting news about AbbVie Inc. The stock has "Market Perform" rating by BMO Capital Markets on Friday, June 10. As per Friday, October 13, the company rating was maintained by UBS. The stock now has an average rating of "Buy" and an average target price of $100.94.

In other news, insider Henry O. Gosebruch sold 18,300 shares of the firm's stock in a transaction on Monday, October 30th. Piper Jaffray maintained AbbVie Inc. Finally, Jefferies Group reissued a "buy" rating and issued a $107.00 price target (up from $94.00) on shares of AbbVie in a research report on Friday, September 15th. Greatmark Investment Partners Inc. grew its holdings in AbbVie by 3.7% during the 2nd quarter. (NYSE:ABBV). Opus reported 1.32% of its portfolio in AbbVie Inc. Systematic Fin Management Lp reported 9,300 shares stake. Boyd Watterson Asset Mngmt Ltd Oh reported 55,686 shares.

Since August 4, 2017, it had 0 insider buys, and 11 sales for $23.10 million activity. $1.66 million worth of AbbVie Inc. (NYSE:ABBV) on Thursday, December 14. 87,040 shares were sold by RICHMOND TIMOTHY J., worth $8.57 million on Monday, December 18. 6,699 shares were sold by Michael Robert A., worth $589,512 on Thursday, September 28. (NYSE:ABBV). 7,407 are held by Headinvest Ltd Liability Com.

In other news, Chairman Richard A. Gonzalez sold 218,193 shares of the business's stock in a transaction dated Tuesday, November 21st.

Investors sentiment decreased to 0.85 in Q3 2017. Its up 0.18, from 1.6 in 2017Q2.

A number of other large investors have also recently bought and sold shares of ABBV. 132 funds opened positions while 462 raised stakes. St. Louis Trust Co grew its position in shares of AbbVie by 0.7% in the 2nd quarter. Shares of ABBV have increased 9.95% in the past three monthswhile the S&P 500 has gained 3.84% in that time. Pictet North America Advsrs reported 3,766 shares. Hilltop Inc has 36,357 shares. Sigma Inv Counselors invested in 0.58% or 45,700 shares. Mrj Capital Inc owns 30,300 shares. Centurylink Invest Mngmt holds 0.32% of its portfolio in AbbVie Inc. Inv Of Virginia has 1.92% invested in AbbVie Inc. (NYSE:ABBV). Sii Investments Incorporated Wi has 0.08% invested in AbbVie Inc. First Personal owns 17,760 shares. 8,583 are held by Natl Bank.